Brief: Pharma Equity Group Achieved In Q1-2023 A Loss After Tax Of DKK 2.9 Million
May 10 (Reuters) - Pharma Equity Group A/S PEGRP.CO :
* CONSOLIDATED INTERIM REPORT 1 JANUARY – 31 MARCH 2023
* MAINTAINS PREVIOUSLY ANNOUNCED EXPECTATIONS FOR 2023
* ACHIEVED IN Q1-2023 A LOSS AFTER TAX OF DKK 2.9 MILLION,
Source text for Eikon: ID:nGNEnFxQP
Further company coverage: PEGRP.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations